Clinical trial Recruiting at 1 site Interventional Ages 55 to 80

Robotic-assisted cataract surgery using the ORYOM system

Official title: Single-site, Open-label, Prospective Feasibility Study Performed Using the JASPER™ Robotic Surgical System in Cataract Surgery Procedures

Run by ForSight Robotics Ltd · NCT07468409 · Data updated 2026-11-12

This will test whether the ORYOM robotic system can safely help perform cataract surgery in adults aged 55 to 80.

Quick facts

Study typeInterventional
Ages55 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorForSight Robotics Ltd
Industry-sponsored
Locations1 site (Makati City, National Capital Region)
StatusRecruiting
StartedFebruary 20, 2026
Main results expectedFebruary 2027
Study endsApril 2027
Registry record updatedJuly 24, 2026
Trial IDNCT07468409 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 55–80 years old with cataract who can dilate adequately, have no prior ocular surgery or significant anterior segment abnormalities, and meet general health criteria.

Probably not a fit

Patients with prior ocular surgery or trauma, polar cataract, zonular instability, pseudoexfoliation, active ocular infection or uveitis, or high anesthetic/surgical risk (ASA > 3) are unlikely to qualify or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, open-label interventional study in which the ORYOM Robotic Surgical System is used during standard cataract operations. Adult patients scheduled for cataract extraction at a single center in Makati will undergo surgery with the robotic system and be followed for perioperative and short-term postoperative outcomes. Key enrollment criteria include age 55–80, clear intraocular media aside from the cataract, and adequate pupil dilation, while patients with prior ocular surgery, polar cataract, zonular instability, pseudoexfoliation, active infection, or uveitis are excluded. The study will record procedural performance metrics, intraoperative safety events, and routine postoperative visual and ocular health outcomes.

Why it matters

Potential benefit: If successful, the system could increase surgical precision and reduce intraoperative complications, potentially improving visual outcomes.

How similar studies have gone: Robotic assistance in ophthalmic surgery is an emerging field with early feasibility reports showing improved instrument stability and precision, but large-scale proof of clinical benefit for cataract outcomes is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Main Inclusion Criteria:

* Patient aged 55 to 80 years
* Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol
* Patients are scheduled to undergo cataract surgery
* Clear intraocular media, other than cataract
* Pupil dilate according to stand of care

Main Exclusion Criteria:

* Prior ocular surgery or trauma in the study eye
* Polar cataract in the study eye
* Zonular instability or significant anterior segment abnormalities
* Active ocular infection or uveitis
* Pseudoexfoliation (PXF) syndrome in either eye
* ASA Physical Status Classification \> 3
* Participation in another clinical trial within 30 days

Where it's running

  • Asian Eye Instiitute
    Makati City, National Capital Region, Philippines
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.